Edwards Lifesciences Profit Margin

Edwards Lifesciences (EW) currently reports a profit margin of 15.43% as of June 2026. That compares with 72.96% in the prior-year period — down 78.8% year over year. That is below the Healthcare sector average of 15.52%. Use the charts on this page to explore Edwards Lifesciences's profit margin history and peer comparisons.

Edwards Lifesciences's profit margin decreased from 72.96% to 15.43% — a 78.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Edwards Lifesciences's profit margin of 15.43% is lower than the Healthcare sector average of 15.52%. That is roughly 0.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Edwards Lifesciences's current 15.43% should be judged against Healthcare norms (sector average: 15.52%) and against EW's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 15.43%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.52%. From there, open related valuation or income-statement pages for Edwards Lifesciences, and consider following EW for alerts when major investors trade the stock.